TLC399
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TLC399, covering 2021-12-23 to 2021-12-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO [Phase 1, Phase 2]